ADMF – Justification and Outcomes of Implementing the Diet Known as Modified Fasting

Adapted Alternate-Day Fasting (ADMF), derived from the modified alternate-day fasting protocol, operates on a cyclical pattern wherein days of unrestricted caloric intake alternate with days of severe energy restriction—limited to just 25% of an individual’s total daily energy expenditure. The most common implementation follows a 1:1 ratio, meaning fasting days occur every other day, interspersed with days of normal eating without caloric constraints. During fasting days, a single meal is typically consumed between 12:00 PM and 2:00 PM, providing approximately one-quarter of the daily caloric requirement—roughly 400–500 kcal for the average woman and 500–600 kcal for the average man, though precise calculations should account for personalized metabolic needs. Non-caloric beverages, such as plain water, unsweetened herbal teas, or black coffee without sugar, are permitted, as is the use of sugar-free chewing gum. However, it is critical to note that this fasting regimen carries numerous contraindications, including childhood and adolescent development phases, chronic kidney or liver diseases, diabetes (particularly type 1), hypothyroidism, pregnancy and breastfeeding, eating disorders such as anorexia nervosa or bulimia, and hormonal imbalances, including irregular menstrual cycles.

Metabolic processes undergo substantial alterations during periods of restricted food intake. Clinical research has demonstrated that the basal metabolic rate increases by 3.6 to 10 percent within the initial 48–60 hours of fasting. This phenomenon is attributed to elevated secretion of the catecholamine neurotransmitters—specifically epinephrine and norepinephrine—which stimulate the central nervous system and enhance overall physiological activity. Comprehensive clinical trials have confirmed that alternate-day modified fasting (ADMF) yields measurable health benefits, including improvements in blood lipid profiles. Of particular significance is the reduction in low-density lipoprotein (LDL) cholesterol concentrations by 10–25 percent. Notably, this approach does not result in the loss of lean muscle mass, a common drawback of conventional calorie-restrictive diets. Additionally, an average body weight reduction of 6–8 percent and a decrease in waist circumference have been documented. Short-term fasting intervals also facilitate adaptation to single-day dietary regimens, with hunger sensations during caloric restriction being less pronounced than under continuous energy deficit conditions. A particularly intriguing finding is that this nutritional model activates the SIRT1 gene, which accelerates lipolysis—the process of fat release and combustion. Despite promising outcomes, the mechanisms underlying the physiological changes induced by ADMF have not yet been fully elucidated. Further investigations are necessary to validate existing observations and assess the long-term consequences of this method. Those interested in the topic may refer to the analysis: *Is fasting an effective or hazardous weight-loss strategy? Effects and potential risks associated with fasting. How to safely conclude a fasting period.*